These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3124432)

  • 21. High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study.
    Preisler HD; Raza A; Barcos M; Azarnia N; Larson R; Browman G; Walker I; Grunwald H; D'Arrigo P; Stein A
    Am J Hematol; 1986 Oct; 23(2):131-4. PubMed ID: 3529939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine arabinoside in patients with myelodysplastic syndrome. A pilot study.
    Ganser A; Ottmann OG; Schulz G; Hoelzer D
    Onkologie; 1989 Feb; 12(1):13-5. PubMed ID: 2654786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of preleukemic syndromes with continuous intravenous infusion of low-dose cytosine arabinoside.
    Griffin JD; Spriggs D; Wisch JS; Kufe DW
    J Clin Oncol; 1985 Jul; 3(7):982-91. PubMed ID: 4020409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Low doses of subcutaneous cytosine arabinoside in the treatment of patients with myelodysplastic syndromes].
    Avilés A; Tripp F; Velásquez A; Rubio ME; González-Llavén J
    Rev Invest Clin; 1988; 40(1):21-4. PubMed ID: 3165541
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of low-dose cytarabine therapy in myelodysplastic syndromes.
    el-Mangoush M; Singh NK
    J Assoc Physicians India; 1992 Jul; 40(7):452-4. PubMed ID: 1484026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aclarubicin and low-dose Cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome: a multicenter study of 112 Chinese patients.
    Li JM; Shen Y; Wu DP; Liang H; Jin J; Chen FY; Song YP; Song EY; Qiu XF; Hou M; Qiu ZC; Shen ZX
    Int J Hematol; 2005 Jul; 82(1):48-54. PubMed ID: 16105759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes.
    Cheson BD; Jasperse DM; Simon R; Friedman MA
    J Clin Oncol; 1986 Dec; 4(12):1857-64. PubMed ID: 3537219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study.
    Venditti A; Scimò MT; del Poeta G; Buccisano F; Stasi R; Mastino A; Grelli S; Favalli C; Garaci E; Papa G
    Leuk Lymphoma; 1995 Jan; 16(3-4):335-42. PubMed ID: 7719240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose cytosine arabinoside (LD-Ara C) treatment in dysmyelopoietic syndromes (DMPS) and acute myelogenous leukemia (AML).
    Jehn U; Göldel N; Vehling-Kaiser U
    Anticancer Res; 1987; 7(3 Pt B):505-8. PubMed ID: 3477124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of retinoic acid, 1,25-dihydroxyvitamin D3, cytosine arabinoside and alpha-interferon on bone marrow cells from patients with myelodysplastic syndromes.
    Hellström E; Robèrt KH; Soppi E; Ost A; Putkonen PO; Gahrton G
    Leuk Res; 1989; 13(12):1113-21. PubMed ID: 2615468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of low-dose cytarabine therapy in myelodysplastic syndromes.
    el Mangoush M; Singh MK; Kumar S; Korajkio M; Gamati A
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():100. PubMed ID: 2627594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low dose cytosine arabinoside in myelodysplasia and acute myelogenous leukemia: a review.
    Bolwell BJ; Cassileth PA; Gale RP
    Leukemia; 1987 Aug; 1(8):575-9. PubMed ID: 3312846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment with intermediate dose cytosine arabinoside for myelodysplastic syndrome with acute myelofibrosis.
    Takabayashi M; Sakai R; Kanamori H; Ishigatsubo Y
    Leuk Lymphoma; 2003 May; 44(5):891-2. PubMed ID: 12802934
    [No Abstract]   [Full Text] [Related]  

  • 35. Response of a case of myelodysplastic syndrome with partial myeloperoxidase deficiency to continuous infusion of low-dose cytosine arabinoside.
    Cheong SK
    Singapore Med J; 1987 Dec; 28(6):577-8. PubMed ID: 2831627
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside.
    Preisler HD; Raza A; Barcos M
    Med Oncol Tumor Pharmacother; 1985; 2(2):87-91. PubMed ID: 4058079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of myelodysplastic syndromes.
    Buzaid AC; Garewal HS; Greenberg BR
    Am J Med; 1986 Jun; 80(6):1149-57. PubMed ID: 3524212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy of advanced myelodysplastic syndrome with aggressive chemotherapy.
    Richard C; Iriondo A; Garijo J; Baro J; Conde E; Recio M; Cuadrado MA; Bello C; Zubizarreta A
    Oncology; 1989; 46(1):6-9. PubMed ID: 2644606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes.
    Invernizzi R; Pecci A; Rossi G; Pelizzari AM; Giusto M; Tinelli C; Ascari E
    Haematologica; 1997; 82(6):660-3. PubMed ID: 9499664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes.
    Invernizzi R; Pecci A; Rossi G; Pelizzari AM; Giusto M; Tinelli C; Ascari E
    Haematologica; 1997; 82(5 Suppl):9-12. PubMed ID: 9402747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.